Pharmaniaga Bhd (7081) - Net Assets
Based on the latest financial reports, Pharmaniaga Bhd (7081) has net assets worth RM459.15 Million MYR (≈ $115.28 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM2.25 Billion ≈ $564.10 Million USD) and total liabilities (RM1.79 Billion ≈ $448.83 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 7081 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | RM459.15 Million |
| % of Total Assets | 20.44% |
| Annual Growth Rate | -0.47% |
| 5-Year Change | -2.4% |
| 10-Year Change | -13.47% |
| Growth Volatility | 55.18 |
Pharmaniaga Bhd - Net Assets Trend (2012–2025)
This chart illustrates how Pharmaniaga Bhd's net assets have evolved over time, based on quarterly financial data. Also explore how large is Pharmaniaga Bhd's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Pharmaniaga Bhd (2012–2025)
The table below shows the annual net assets of Pharmaniaga Bhd from 2012 to 2025. For live valuation and market cap data, see 7081 stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | RM459.15 Million ≈ $115.28 Million |
+414.61% |
| 2024-12-31 | RM-145.94 Million ≈ $-36.64 Million |
+46.75% |
| 2023-12-31 | RM-274.09 Million ≈ $-68.81 Million |
+21.31% |
| 2022-12-31 | RM-348.31 Million ≈ $-87.45 Million |
-174.04% |
| 2021-12-31 | RM470.44 Million ≈ $118.11 Million |
+39.38% |
| 2020-12-31 | RM337.53 Million ≈ $84.74 Million |
-0.10% |
| 2019-12-31 | RM337.85 Million ≈ $84.82 Million |
-33.67% |
| 2018-12-31 | RM509.34 Million ≈ $127.88 Million |
-3.54% |
| 2017-12-31 | RM528.05 Million ≈ $132.57 Million |
-0.49% |
| 2016-12-31 | RM530.63 Million ≈ $133.22 Million |
-5.24% |
| 2015-12-31 | RM560.00 Million ≈ $140.60 Million |
+1.45% |
| 2014-12-31 | RM552.00 Million ≈ $138.59 Million |
+9.74% |
| 2013-12-31 | RM503.00 Million ≈ $126.29 Million |
+3.07% |
| 2012-12-31 | RM488.00 Million ≈ $122.52 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Pharmaniaga Bhd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 74.5% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | RM97.06 Million | 22.34% |
| Common Stock | RM243.43 Million | 56.03% |
| Other Comprehensive Income | RM-7.21 Million | -1.66% |
| Other Components | RM101.18 Million | 23.29% |
| Total Equity | RM434.47 Million | 100.00% |
Pharmaniaga Bhd Competitors by Market Cap
The table below lists competitors of Pharmaniaga Bhd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BlackRock Energy and Resources Closed Fund
NYSE:BGR
|
$411.63 Million |
|
Panda Dairy Corp
SHE:300898
|
$411.71 Million |
|
Cedar Woods Properties Ltd
AU:CWP
|
$411.74 Million |
|
Landsea Homes Corp
NASDAQ:LSEA
|
$411.79 Million |
|
Summit Midstream Corporation
NYSE:SMC
|
$411.54 Million |
|
Yuanbao Inc. American Depositary Shares
NASDAQ:YB
|
$411.37 Million |
|
Fidere Patrimonio SOCIMI SA
MC:YFID
|
$411.03 Million |
|
MN Holdings Berhad
KLSE:0245
|
$410.85 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Pharmaniaga Bhd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -171,275,000 to 434,466,000, a change of 605,741,000.
- Net income of 48,510,000 contributed positively to equity growth.
- Share repurchases of 569,569,000 reduced equity.
- New share issuances of 569,569,000 increased equity.
- Other comprehensive income decreased equity by 7,205,999.
- Other factors increased equity by 564,436,999.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | RM48.51 Million | +11.17% |
| Share Repurchases | RM569.57 Million | -131.1% |
| Share Issuances | RM569.57 Million | +131.1% |
| Other Comprehensive Income | RM-7.21 Million | -1.66% |
| Other Changes | RM564.44 Million | +129.92% |
| Total Change | RM- | % |
Book Value vs Market Value Analysis
This analysis compares Pharmaniaga Bhd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.08x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.61x to 2.08x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | RM0.41 | RM0.25 | x |
| 2017-12-31 | RM0.41 | RM0.25 | x |
| 2018-12-31 | RM0.39 | RM0.25 | x |
| 2019-12-31 | RM0.26 | RM0.25 | x |
| 2020-12-31 | RM0.26 | RM0.25 | x |
| 2021-12-31 | RM0.34 | RM0.25 | x |
| 2022-12-31 | RM-0.28 | RM0.25 | x |
| 2023-12-31 | RM-0.22 | RM0.25 | x |
| 2024-12-31 | RM-0.12 | RM0.25 | x |
| 2025-12-31 | RM0.12 | RM0.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Pharmaniaga Bhd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.17%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.24%
- • Asset Turnover: 1.75x
- • Equity Multiplier: 5.17x
- Recent ROE (11.17%) is above the historical average (5.12%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 15.87% | 3.84% | 1.46x | 2.83x | RM31.06 Million |
| 2016 | 8.59% | 2.08% | 1.30x | 3.17x | RM-7.46 Million |
| 2017 | 10.19% | 2.32% | 1.45x | 3.04x | RM1.02 Million |
| 2018 | 8.34% | 1.78% | 1.25x | 3.75x | RM-8.47 Million |
| 2019 | -44.17% | -5.29% | 1.77x | 4.71x | RM-183.00 Million |
| 2020 | 8.14% | 1.01% | 1.72x | 4.68x | RM-6.26 Million |
| 2021 | 38.22% | 3.58% | 2.13x | 5.01x | RM127.10 Million |
| 2022 | 0.00% | -18.10% | 1.88x | 0.00x | RM-592.95 Million |
| 2023 | 0.00% | -2.35% | 1.78x | 0.00x | RM-50.25 Million |
| 2024 | 0.00% | 3.51% | 1.89x | 0.00x | RM148.95 Million |
| 2025 | 11.17% | 1.24% | 1.75x | 5.17x | RM5.06 Million |
Industry Comparison
This section compares Pharmaniaga Bhd's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $194,904,850
- Average return on equity (ROE) among peers: 15.31%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Pharmaniaga Bhd (7081) | RM459.15 Million | 15.87% | 3.89x | $411.56 Million |
| BCM Alliance Bhd (0187) | $46.58 Million | 17.66% | 0.67x | $5.11 Million |
| Apex Healthcare Bhd (7090) | $343.23 Million | 12.95% | 0.33x | $473.43 Million |
About Pharmaniaga Bhd
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines… Read more